BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Merck Invests €25M to Expand BioReliance Testing Capabilities in Europe

• New 2,000-square-meter facility expands Merck’s global testing network with commercial drug substance and drug product release testing a...

July 17, 2026 | News

GEM Commits Up to $15.5M to Back Senhwa Biosciences’ Oncology Pipeline

GEM Global Yield LLC SCS ("GEM") has executed a Share Purchase Agreement (the "SPA") with the existing shareholders of Taiwan-listed Senhwa Biosciences Inc...

July 16, 2026 | News

Takeda Backs Indonesia's Plasma Ambitions with US$30 Million Investment to Build ASEAN's First Integrated Plasma Ecosystem

Ministry of Health of the Republic of Indonesia Grants Plasma Fractionation License, Enabling Takeda to Collect and Fractionate Plasma as Part of Multi...

July 14, 2026 | News

Australia's Second Plasma Fractionation Facility Targets Rising Import Dependence for Critical Plasma Medicines

AUSTRALIA SET TO IMPORT 70% OF VITAL PLASMA DERIVED MEDICINES BY 2030: NSW PRODUCTIVITY COMMISSION Australian biotech Aegros has completed A...

July 10, 2026 | News

Healome Therapeutics Raises £2 Million Seed Funding to Advance Eye-Drop Platform for Ocular Surface Diseases

Healome Therapeutics ("Healome"), a University of Birmingham spinout developing a proprietary eye-drop matrix technology for ocular surface diseases, has c...

July 09, 2026 | News

Vitex Inaugurates A$250M Wonderland Manufacturing Hub in Western Sydney

Vitex Pharmaceuticals Pty Ltd has officially inaugurated Wonderland, its new A$250 million pharmaceutical manufacturing facility at Eastern Creek in Wester...

July 06, 2026 | News

Icosagen Completes €45 Million Expansion to Deliver End-to-End Biologics Development and GMP Manufacturing at a Single Site

Estonia-based biotechnology company Icosagen has completed a major strategic expansion to strengthen its integrated biologics development and man...

July 01, 2026 | News

ChemT Biotechnology Raises US$5 Million to Advance AI-Powered Biomanufacturing Platform

The total funding comprises US$1 million in angel investment and a US$4 million seed round. The seed financing round was led by Wavem...

June 23, 2026 | News

Rejuvenate Bio and Merck Animal Health Join Forces on Novel Animal Health Gene Therapy Programme

-- Lifespan Vision Ventures (LVV), an investment firm focused on therapeutics that improve human healthspan, congratulates its portfolio company Rejuvenate...

June 15, 2026 | News

XtalPi Lands $400M+ AI-Driven Drug Discovery Partnership for Metabolic GPCR Target

XtalPi (2228.HK), a leading platform in artificial intelligence (AI) and robotics-driven drug discovery, announced a strategic partnership with a pro...

June 12, 2026 | News

LongBio Pharma Debuts on Hong Kong Exchange With HK$10.7 Billion Valuation

LongBio Pharma, a portfolio company of Qiming Venture Partners and a leading innovative drug developer for allergic and autoimmune diseases in China, liste...

June 08, 2026 | News

Samsung Epis Holdings Establishes First Global R&D Hub in Beijing to Advance ADC and Novel Drug Development

Establishes its first global research base as part of strategic new business expansion under the holding company structure Ÿ B...

June 03, 2026 | News

Lilly Secures Global Rights To Hanmi's Sonefpeglutide In Potential $1.26 Billion Deal

Lilly licenses Hanmi's sonefpeglutide (LAPSGLP-2 analog) for multiple indications Hanmi Pharm. Co., Ltd. ("Hanmi") announced that they have entered i...

June 02, 2026 | News

Pfizer And Innovent Biologics Forge Global Oncology Alliance Covering 12 Cancer Programs

Pfizer Inc. and Innovent Biologics, Inc. announced the companies have entered into a strategic global licensing and collaboration agreement for the r...

June 01, 2026 | News

Stay Connected